Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
A 57-Year-Old Man Diagnosed with Non-Clear Cell, Renal Cell Carcinoma (nccRCC)
March 4th 2024Dr. Robert Motzer shares his clinical perspectives and insights on the management of patients with nccRCC, including initial therapy considerations, emerging data on combination regimens, adverse events and the future landscape.
Read More
A 59-Year-Old African American Woman with Clear Cell, Renal Cell Carcinoma (ccRCC)
February 13th 2024Expert Hans Hammers, MD, reviews a case of a 59-year-old African American woman who underwent nephrectomy for left renal mass revealing clear cell RCC, who later developed metastatic disease managed initially with pembrolizumab and lenvatinib.
Read More
Bispecific Antibodies: Operationalizing Administration and Follow-Up
December 14th 2023Brooke Peters, PharmD, BCOP, shares her insight on institutional program development and operationalizing of bispecifics administration, highlighting its key components, roles involved, and clinical consideration for the management of related toxicities.
Read More
A 62-Year-Old Female with Stage IV BRAF-Mutated Melanoma
November 30th 2023Michael B Atkins, MD, discusses first-line treatment options for a patient with stage IV BRAF-mutated melanoma. He also reviews data that may help guide treatment and sequencing decisions for patients with metastatic melanoma.
Read More
A 66-Year-Old Man with Relapsed/Refractory Multiple Myeloma (RRMM)
October 23rd 2023Rafael Fonseca, MD, discusses treatment considerations for a 66-year-old man with relapsed/refractory multiple myeloma after several prior therapies, and highlights recent clinical trial results with novel BCMA-targeted bispecific antibodies and other therapies in the relapsed/refractory setting.
Read More
A 71-Year-Old Woman with Relapsed/Refractory Multiple Myeloma (RRMM)
September 27th 2023Ajai Chari, MD, presents the case of a woman with relapsed/refractory multiple myeloma and discusses the available treatment options for patients with more than 4 prior lines of therapy, referencing recent key clinical trial data.
Read More
A 72-Year-Old Woman with Single Lineage Dysplasia MDS
September 6th 2023Jamie L. Koprivnikar, MD, presents the case of a 72-year-old woman with single lineage dysplasia myelodysplastic syndrome, reviews the typical treatment approaches, and shares key data from a subgroup analysis of the COMMANDS trial presented at the ASCO and EHA 2023 Annual Meetings.
Read More